75+ Pharma Products for Technology Transfer — Oncology, GLP-1, Cardiovascular, Ophthalmics

Pharmaceutical vial and growth analytics

Therapeutic Areas

Six Categories, Global Reach

Every molecule includes complete technology transfer packages with CTD documentation scoped per programme.

Oncology

19 molecules — monoclonal antibodies, cytotoxics, and targeted therapies for breast, lung, colorectal, and blood cancers.

💉

Diabetes & GLP-1

8 molecules — next-generation peptide therapeutics including Semaglutide, Tirzepatide, and insulin analogs.

❤️

Cardiovascular

21 molecules — anticoagulants, antihypertensives, lipid-lowering agents, and PCSK9 inhibitors.

🫁

Respiratory

8 molecules — inhalers, corticosteroids, and biologics for asthma, COPD, and allergic conditions.

🛡️

Immunology

8 molecules — advanced biologics and immunosuppressants for autoimmune and transplant conditions.

👁️

Ophthalmics

11 molecules — intravitreal injectables, topical drops, and combination products for retinal and glaucoma disorders.

Complete Catalog

Full Molecule Portfolio

Click a category to explore molecules for technology transfer. Finished-dose oral partner-supply pages are in the last tab.

#	Molecule	Brand Reference	Primary Use	Dosage Form	Status
1	Paclitaxel NAB	Abraxane®	Breast, ovarian, lung cancers	IV Injectable	Available
2	Pemetrexed	Alimta®	Lung cancer, mesothelioma	IV Injectable	Available
3	Gemcitabine	Gemzar®	Pancreatic, lung, breast cancers	IV Injectable	Available
4	Doxorubicin	Adriamycin®	Breast, lung, leukemia	IV Injectable	Available
5	Oxaliplatin	Eloxatin®	Colorectal cancer	IV Injectable	Available
6	Carboplatin	Paraplatin®	Ovarian, lung, head & neck cancers	IV Injectable	Available
7	Cisplatin	Platinol®	Testicular, bladder, lung cancers	IV Injectable	Available
8	Docetaxel	Taxotere®	Breast, prostate, NSCLC	IV Injectable	Available
9	Irinotecan	Camptosar®	Colorectal cancer	IV Injectable	Available
10	Bortezomib	Velcade®	Multiple myeloma	IV / SC Injectable	Available
11	Trastuzumab	Herceptin®	HER2+ breast cancer	IV Injectable	Available
12	Bevacizumab	Avastin®	Colorectal, lung, renal cancers	IV Injectable	Available
13	Rituximab	MabThera®	Non-Hodgkin lymphoma, CLL	IV Injectable	Available
14	Pembrolizumab	Keytruda®	Melanoma, NSCLC, multiple solid tumors	IV Injectable	Available
15	Nivolumab	Opdivo®	Melanoma, renal, lung cancers	IV Injectable	Available
16	Etoposide	VePesid®	Small cell lung, testicular cancers	IV Injectable	Available
17	Vincristine	Oncovin®	Leukemia, lymphoma	IV Injectable	Available
18	Fluorouracil (5-FU)	Adrucil®	Colorectal, breast, gastric cancers	IV Injectable	Available
19	Methotrexate (Oncology)	Trexall®	ALL, lymphoma, osteosarcoma	IV / SC Injectable	Available

#	Molecule	Brand Reference	Primary Use	Dosage Form	Status
1	Semaglutide	Ozempic® / Wegovy®	Type 2 diabetes, weight management	SC Injectable / Oral	Available
2	Tirzepatide	Mounjaro® / Zepbound®	Type 2 diabetes, obesity	SC Injectable	Available
3	Liraglutide	Victoza® / Saxenda®	Type 2 diabetes, weight management	SC Injectable	Available
4	Dulaglutide	Trulicity®	Type 2 diabetes	SC Injectable	Available
5	Insulin Glargine	Lantus® / Toujeo®	Type 1 & 2 diabetes	SC Injectable	Available
6	Insulin Aspart	NovoRapid®	Type 1 & 2 diabetes	SC Injectable	Available
7	Insulin Lispro	Humalog®	Type 1 & 2 diabetes	SC Injectable	Available
8	Sitagliptin	Januvia®	Type 2 diabetes	Oral Tablet	Available

#	Molecule	Brand Reference	Primary Use	Dosage Form	Status
1	Enoxaparin	Lovenox®	DVT prevention, ACS	SC Injectable	Available
2	Heparin Sodium	—	Anticoagulation	IV / SC Injectable	Available
3	Fondaparinux	Arixtra®	DVT, PE prevention	SC Injectable	Available
4	Warfarin	Coumadin®	Anticoagulation	Oral Tablet	Available
5	Clopidogrel	Plavix®	Antiplatelet, ACS	Oral Tablet	Available
6	Evolocumab	Repatha®	Hyperlipidemia (PCSK9)	SC Injectable	Available
7	Alirocumab	Praluent®	Hyperlipidemia (PCSK9)	SC Injectable	Available
8	Rosuvastatin	Crestor®	Hyperlipidemia	Oral Tablet	Available
9	Atorvastatin	Lipitor®	Hyperlipidemia	Oral Tablet	Available
10	Amlodipine	Norvasc®	Hypertension, angina	Oral Tablet	Available
11	Losartan	Cozaar®	Hypertension	Oral Tablet	Available
12	Valsartan	Diovan®	Hypertension, heart failure	Oral Tablet	Available
13	Metoprolol	Lopressor®	Hypertension, angina, HF	Oral Tablet	Available
14	Bisoprolol	Zebeta®	Hypertension, heart failure	Oral Tablet	Available
15	Ramipril	Altace®	Hypertension, heart failure	Oral Capsule	Available
16	Lisinopril	Zestril®	Hypertension, heart failure	Oral Tablet	Available
17	Empagliflozin	Jardiance®	Heart failure, diabetes	Oral Tablet	Available
18	Dapagliflozin	Farxiga®	Heart failure, CKD	Oral Tablet	Available
19	Sacubitril/Valsartan	Entresto®	Heart failure	Oral Tablet	Available
20	Digoxin	Lanoxin®	Heart failure, atrial fibrillation	Oral / IV	Available
21	Amiodarone	Cordarone®	Ventricular arrhythmias	Oral / IV	Available

#	Molecule	Brand Reference	Primary Use	Dosage Form	Status
1	Fluticasone / Salmeterol	Advair®	Asthma, COPD	Inhaler (DPI/MDI)	Available
2	Budesonide / Formoterol	Symbicort®	Asthma, COPD	Inhaler (MDI)	Available
3	Ciclesonide	Alvesco®	Asthma	Inhaler (MDI)	Available
4	Budesonide	Pulmicort®	Asthma	Nebulizer / Inhaler	Available
5	Montelukast	Singulair®	Asthma, allergic rhinitis	Oral Tablet	Available
6	Fluticasone	Flovent®	Asthma, COPD	Inhaler (MDI)	Available
7	Tiotropium	Spiriva®	COPD	Inhaler (DPI)	Available
8	Mepolizumab	Nucala®	Severe eosinophilic asthma	SC Injectable	Available

#	Molecule	Brand Reference	Primary Use	Dosage Form	Status
1	Adalimumab	Humira®	Rheumatoid arthritis, Crohn's, psoriasis	SC Injectable	Available
2	Dupilumab	Dupixent®	Atopic dermatitis, asthma	SC Injectable	Available
3	Secukinumab	Cosentyx®	Psoriasis, psoriatic arthritis	SC Injectable	Available
4	Ustekinumab	Stelara®	Psoriasis, Crohn's, UC	SC / IV Injectable	Available
5	Infliximab	Remicade®	RA, Crohn's, UC, psoriasis	IV Injectable	Available
6	Etanercept	Enbrel®	RA, psoriasis, ankylosing spondylitis	SC Injectable	Available
7	Methotrexate	Trexall®	Rheumatoid arthritis, psoriasis	Oral / SC Injectable	Available
8	Mycophenolate	CellCept®	Transplant immunosuppression	Oral / IV	Available

#	Molecule	Brand Reference	Primary Use	Dosage Form	Status
1	Aflibercept	Eylea®	Wet AMD, DME, macular edema	Intravitreal Injection	Available
2	Faricimab	Vabysmo®	Wet AMD, DME	Intravitreal Injection	Available
3	Ranibizumab	Lucentis®	Wet AMD, DME, RVO	Intravitreal Injection	Available
4	Lifitegrast	Xiidra®	Dry eye disease	Ophthalmic Solution	Available
5	Cyclosporine	Restasis®	Dry eye disease	Ophthalmic Emulsion	Available
6	Bimatoprost	Lumigan®	Glaucoma, ocular hypertension	Ophthalmic Solution	Available
7	Netarsudil	Rhopressa®	Glaucoma, ocular hypertension	Ophthalmic Solution	Available
8	Netarsudil / Latanoprost	Rocklatan®	Glaucoma, ocular hypertension	Ophthalmic Solution	Available
9	Latanoprostene Bunod	Vyzulta®	Glaucoma, ocular hypertension	Ophthalmic Solution	Available
10	Bromfenac	Prolensa®	Post-operative ocular inflammation	Ophthalmic Solution	Available
11	Nepafenac	Nevanac®	Post-operative ocular pain/inflammation	Ophthalmic Suspension	Available

#	Molecule	Identification name	Class, as described for partners	Dosage form	Status
1	Sitagliptin	Januvia	Dipeptidyl peptidase-4 (DPP-4) inhibitor in the established oral class used in type 2 diabetes	Oral solid	Partner supply
2	Sitagliptin / metformin	Janumet, including Janumet XR	DPP-4 inhibitor with metformin in the established oral class used in type 2 diabetes	Oral solid	Partner supply
3	Ticagrelor	Brilinta	Oral P2Y12 receptor antagonist in the established antiplatelet class	Oral solid	Partner supply
4	Sacubitril / valsartan	Entresto	Angiotensin receptor-neprilysin inhibitor in the established oral class used in chronic heart failure	Oral solid	Partner supply
5	Palbociclib	Ibrance	Cyclin-dependent kinase 4 and 6 inhibitor in the established oral class used in certain hormone receptor-positive breast cancers	Oral solid	Partner supply
6	Metformin	Glucophage	Biguanide in the established oral class used in type 2 diabetes	Oral solid	Partner supply
7	Atorvastatin	Lipitor	HMG-CoA reductase inhibitor (statin) in the established oral lipid-lowering class	Oral solid	Partner supply
8	Rosuvastatin	Crestor	HMG-CoA reductase inhibitor (statin) in the established oral lipid-lowering class	Oral solid	Partner supply
9	Simvastatin	Zocor	HMG-CoA reductase inhibitor (statin) in the established oral lipid-lowering class	Oral solid	Partner supply
10	Losartan	Cozaar	Angiotensin II receptor blocker in the established oral cardiovascular class	Oral solid	Partner supply
11	Valsartan	Diovan	Angiotensin II receptor blocker in the established oral cardiovascular class	Oral solid	Partner supply
12	Lisinopril	Prinivil and Zestril	Angiotensin-converting enzyme inhibitor in the established oral cardiovascular class	Oral solid	Partner supply
13	Amlodipine	Norvasc	Dihydropyridine calcium-channel blocker in the established oral cardiovascular class	Oral solid	Partner supply
14	Metoprolol	Lopressor and Toprol-XL	Beta-blocker in the established oral cardiovascular class	Oral solid	Partner supply
15	Clopidogrel	Plavix	Thienopyridine P2Y12 inhibitor in the established oral antiplatelet class	Oral solid	Partner supply
16	Azithromycin	Zithromax	Macrolide in the established oral antibacterial class	Oral solid	Partner supply
17	Ciprofloxacin	Cipro	Fluoroquinolone in the established oral antibacterial class	Oral solid	Partner supply
18	Doxycycline	Vibramycin	Tetracycline-class antibacterial in the established oral class	Oral solid	Partner supply
19	Cephalexin	Keflex	First-generation cephalosporin in the established oral antibacterial class	Oral solid	Partner supply
20	Omeprazole	Prilosec	Proton pump inhibitor in the established oral acid-suppression class	Oral solid	Partner supply
21	Pantoprazole	Protonix	Proton pump inhibitor in the established oral acid-suppression class	Oral solid	Partner supply
22	Sertraline	Zoloft	Selective serotonin reuptake inhibitor in the established oral class	Oral solid	Partner supply
23	Escitalopram	Lexapro	Selective serotonin reuptake inhibitor in the established oral class	Oral solid	Partner supply
24	Gabapentin	Neurontin	Gabapentinoid in the established oral central nervous system class	Oral solid	Partner supply
25	Celecoxib	Celebrex	Selective COX-2 inhibitor in the established oral non-steroidal anti-inflammatory class	Oral solid	Partner supply

Identification names are for partner recognition only and are not Burrard trademarks. Strengths, packs, and dossier status are confirmed under CDA. These pages do not claim FDA, EMA, or Health Canada product approval.

Showing 75 molecules across 6 therapeutic categories. Custom molecule development also available.

Request Product Details Tech Transfer & CTD

Technology Transfer

Ready for Technology Transfer?

Each molecule package includes master formulas, analytical methods, stability data, CTD/eCTD templates, and manufacturing protocols. Scope and timing are confirmed per programme after a confidentiality agreement.

Request a Programme Review

75+ Molecules for Technology Transfer